FACTORS DETERMINING CLINICAL RESPONSE TO 5′-AZACITDINE AND SODIUM VALPROATE COMBINATION THERAPY IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA
Craddock C., Siddique S., McSkeane T., Griffiths M., Pillai S., Cavenagh J., Vyas P.